Randomized Trial of the Immunogenicity and Safety of the Hepatitis B Vaccine Given in an Accelerated Schedule Coadministered with the Human Papillomavirus Type 16/18 AS04-Adjuvanted Cervical Cancer Vaccine

The human papillomavirus type 16/18 (HPV-16/18) AS04-adjuvanted cervical cancer vaccine is licensed for females aged 10 years and above and is therefore likely to be coadministered with other licensed vaccines, such as hepatitis B. In this randomized, open-label study, we compared the immunogenicity...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Leroux-Roels, Geert, Haelterman, Edwige, Maes, Cathy, Levy, Jack, De Boever, Fien, Licini, Laurent, David, Marie-Pierre, Dobbelaere, Kurt, Descamps, Dominique
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2011
Assuntos:
Vaccine Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3165228/
https://ncbi.nlm.nih.gov/pubmed/21734063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00539-10
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados